surufatinib,serplulimab,etoposide,carboplatin
Showing 1 - 1 of 1
Small Cell Lung Cancer Trial in Fuzhou (Surufatinib,Serplulimab,Etoposide,Carboplatin)
Not yet recruiting
- Small Cell Lung Cancer
- Surufatinib,Serplulimab,Etoposide,Carboplatin
-
Fuzhou, Fujian, ChinaFujian Cancer Hospital
May 20, 2023